Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Marfella R et al. – The authors data suggest that dipeptidyl peptidase IV inhibition therapy should target not only reducing HbA1c but also flattening acute glucose fluctuations over a daily period.

 

Related Articles

Glucose Regulation in Acute Stroke Patients (GRASP) Trial. A Randomized Pilot Trial
Stroke, 10/27/09    Relevance Score: 67%

Acute altitude-induced hypoxia suppresses plasma glucose and leptin in healthy humans
Metabolism-Clinical and Experimental, 10/09/09    Relevance Score: 67%

Oral nitrate therapy does not affect glucose metabolism in healthy men
Clinical and Experimental Pharmacology and Physiology, 11/13/09    Relevance Score: 66%

Acute insulin resistance following injury
Trends in Endocrinology and Metabolism, 10/19/09    Relevance Score: 66%

Phosphatidyl Inositol 3-Kinase Signaling in Hypothalamic Proopiomelanocortin Neurons Contributes to the Regulation of Glucose Homeostasis
Endocrinology, 10/15/09    Relevance Score: 66%

Today in Diabetes...keeping you current

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09

Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09

Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address